ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 23 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $949,503 | -20.5% | 82,926 | -28.6% | 0.00% | -100.0% |
| Q2 2023 | $1,194,279 | +17.3% | 116,175 | +21.0% | 0.00% | 0.0% |
| Q1 2021 | $1,018,000 | +76.4% | 96,017 | +109.8% | 0.00% | – |
| Q4 2020 | $577,000 | +42.5% | 45,771 | -0.6% | 0.00% | – |
| Q3 2020 | $405,000 | +495.6% | 46,058 | +330.7% | 0.00% | – |
| Q3 2018 | $68,000 | -38.2% | 10,694 | -22.0% | 0.00% | – |
| Q1 2018 | $110,000 | -46.3% | 13,705 | -25.0% | 0.00% | – |
| Q4 2017 | $205,000 | – | 18,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $27,257,000 | 2.19% |
| Omega Fund Management, LLC | 1,284,900 | $13,620,000 | 1.29% |
| Samsara BioCapital, LLC | 399,190 | $4,231,000 | 0.78% |
| Soleus Capital Management, L.P. | 313,064 | $3,318,000 | 0.60% |
| Avidity Partners Management LP | 1,511,000 | $16,017,000 | 0.44% |
| Dorsey Wright & Associates | 3,380 | $35,828,000 | 0.42% |
| EcoR1 Capital, LLC | 741,290 | $7,858,000 | 0.35% |
| Orbimed Advisors | 3,070,955 | $32,552,000 | 0.30% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $1,460,000 | 0.29% |
| DAFNA Capital Management LLC | 113,302 | $1,201,000 | 0.28% |